ClinicalTrials.Veeva

Menu

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy. (hyperPOC)

I

Instituto Valenciano de Infertilidad, IVI VALENCIA

Status

Completed

Conditions

Pregnancy Test

Treatments

Diagnostic Test: Pregnancy test

Study type

Interventional

Funder types

Other

Identifiers

NCT03184519
1701-VLC-011-EB

Details and patient eligibility

About

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Enrollment

156 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Patients undergoing their first or second IVF-ET cycle
  • Age 18-45 years
  • Use of Ovitrelle for final follicular maturation and luteinization
  • Fresh or Frozen day-5 blastocysts transrer (Autologus or Egg donation)

Exclusion criteria

  • Gestational surrogacy (patient's eggs used for pregnancy in a surrogate mother)
  • Canceled IVF cycles
  • GnRH agonist triggering cycles in the case of fresh ET.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

156 participants in 1 patient group

All patients
Experimental group
Description:
Patients will undergo 3 blood samples after IVF-ET (pregnancy test) to determine pregnancy.
Treatment:
Diagnostic Test: Pregnancy test

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems